HEATHER BASTEL: Open Payments
NPI 1396712287 · PARAGOULD, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 18 payments from 7 companies in 2025. Trend: 2023 $953 · 2024 $533 · 2025 $371
Food & beverage: $371
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $128 |
| Novo Nordisk Inc | 5 | $112 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| Axsome Therapeutics, Inc. | 1 | $38 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Amgen Inc. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $3 |
Products named: REXULTI, Ozempic, AIRSUPRA, Auvelity, Wegovy, TRELEGY ELLIPTA, OTEZLA, VOQUEZNA.
Industry payments across AR — which companies pay providers there.
